For the Inventor, By the Inventor

Enter assignee name

Nanocarrier Co., Ltd.

USPTO Granted Patents = 23

CIPO Patents = 6

EPO Patents = 18

Trademarks = 1

Forward Citations = 99

Loading Chart...

Loading Chart...

51 inventors (with patents filed for the assignee):

Yasuki Kato (12 out of 14 patents)

Kazunori Kataoka (11 out of 77 patents)

Nobuhiro Nishiyama (6 out of 34 patents)

4. Mitsunori Harada (6 out of 7 patents)

5. Yukio Nagasaki (5 out of 41 patents)

6. Atsushi Ishii (4 out of 72 patents)

7. Kanjiro Miyata (4 out of 20 patents)

8. Naoya Shibata (4 out of 13 patents)

9. Shigeto Fukushima (3 out of 10 patents)

10. Takashi Shimizu (2 out of 148 patents)

11. Hiroyasu Takemoto (2 out of 12 patents)

12. Sumiyo Watanabe (2 out of 3 patents)

13. Kensuke Osada (2 out of 5 patents)

14. Hiroyuki Chaya (2 out of 4 patents)

15. Katsutoshi Kobayashi (2 out of 2 patents)

23 patents: Sort by Forward Citations

1. 11020418 - Unit structure-type pharmaceutical composition for nucleic acid delivery (2021-06-01),

2. 9920133 - Anti-tissue factor monoclonal antibody (2018-03-20),

3. 9808480 - Unit structure-type pharmaceutical composition for nucleic acid delivery (2017-11-07),

4. 9795563 - Particulate pharmaceutical composition (2017-10-24),

5. 9561284 - Pharmaceutical composition containing a block copolymer bound to a boronic acid compound (2017-02-07),

6. 9415059 - Particulate composition and pharmaceutical composition containing the same (2016-08-16),

7. 9278075 - Particle composition and pharmaceutical composition using particle composition (2016-03-08),

8. 9198860 - Particulate pharmaceutical composition (2015-12-01),

9. 9114177 - Block copolymer having phenylboronic acid group introduced therein, and use thereof (2015-08-25),

10. RE45471 - Pharmaceutical composition or combination drug (2015-04-13),

11. 8895076 - Liquid composition of cisplatin coordination compound (2014-11-25),

12. 8853167 - Short-chain cationic polyamino acid and use thereof (2014-10-07),

13. 8574601 - Sustained-release polymer micelle disruptable by HDL (2013-11-05),

14. 8519051 - Block copolymer for drug conjugates and pharmaceutical composition (2013-08-27),

15. 8436044 - Pharmaceutical composition or combination drug (2013-05-07),

Nanocarrier Co., Ltd. is a leading pharmaceutical company specializing in nanomedicine. With a strong focus on research and development, Nanocarrier aims to revolutionize drug delivery systems to provide innovative and effective treatments for various diseases. Through advanced nanotechnology, the company develops nano-sized carriers, enabling targeted and efficient drug delivery to specific cells or tissues. Nanocarrier's innovative solutions have the potential to significantly enhance the efficacy and safety of therapeutic treatments. Visit their website for more information.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

23 Patents

#2 in Kashiwa

#2,647 in Japan

#26,824 in the World

Nanocarrier Co., Ltd.

Forward Citations = 99

51 inventors:

Yasuki Kato (12 out of 14 patents)

Kazunori Kataoka (11 out of 77 patents)

Nobuhiro Nishiyama (6 out of 34 patents)

4. Mitsunori Harada (6 out of 7 patents)

5. Yukio Nagasaki (5 out of 41 patents)

Please report any incorrect information to support@idiyas.com

Loading…